Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 3 (NPM1P3)

Target
NPM1P3
Molecular classification
Other (Pseudogene)
01

Overview

Nucleophosmin 1 pseudogene 3 (NPM1P3) is a processed pseudogene related to the functional NPM1 gene, which encodes nucleophosmin, a multifunctional nucleolar protein involved in ribosome biogenesis, cell cycle regulation, and genomic stability[1][3][5][7]. As a pseudogene, NPM1P3 does not encode a functional protein and is not implicated as a therapeutic target, biomarker, or disease modulator. Information on NPM1P3 is scarce, as research and clinical interest are centered on the functional NPM1 gene and its variants, which play well-defined roles in cancer biology, especially acute myeloid leukemia[6]. There is no established role for NPM1P3 in normal or disease biology, drug interactions, or as a therapeutic biomarker. NPM1P3 is not a protein-coding gene and therefore not a receptor, enzyme, transporter, or other classical drug target type. The designation “pseudogene” means it is a nonfunctional segment of DNA resembling the NPM1 gene, likely arising from gene duplication or retrotransposition. The main target of biomedical interest is the functional NPM1 gene (Nucleophosmin 1)[1][3][5][6][7]. There is no evidence in the literature that NPM1P3 is involved in disease or targeted by drugs. Nucleophosmin 1 pseudogene 3 (NPM1P3) is a nonfunctional genetic element and not considered a molecular target in drug discovery or biomedical research. There is nothing inherently therapeutic or actionable about this entity; if a functional or disease-related NPM1 target is intended, information about the NPM1 gene/protein should be sought instead.

Other names
NG3-3Nucleophosmin pseudogene 3

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 3 (NPM1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 3 (NPM1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call